Viridian Therapeutics Management
Management criteria checks 1/4
Viridian Therapeutics' CEO is Steve Mahoney, appointed in Oct 2023, has a tenure of 1.08 years. total yearly compensation is $13.02M, comprised of 0.9% salary and 99.1% bonuses, including company stock and options. directly owns 0.027% of the company’s shares, worth $432.35K. The average tenure of the management team and the board of directors is 1.1 years and 4.1 years respectively.
Key information
Steve Mahoney
Chief executive officer
US$13.0m
Total compensation
| CEO salary percentage | 0.9% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1.1yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
We're Not Very Worried About Viridian Therapeutics' (NASDAQ:VRDN) Cash Burn Rate
Nov 14
Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Sep 11Viridian: Active TED Data Signifies Next Round Of Positive Data On The Way
Sep 10Viridian Therapeutics: Key Catalysts Coming In The Second Half Of The Year
Jun 12Is Viridian Therapeutics (NASDAQ:VRDN) Using Debt Sensibly?
May 28Despite Lacking Profits Viridian Therapeutics (NASDAQ:VRDN) Seems To Be On Top Of Its Debt
Sep 12Is There An Opportunity With Viridian Therapeutics, Inc.'s (NASDAQ:VRDN) 44% Undervaluation?
May 15Is Viridian Therapeutics (NASDAQ:VRDN) Weighed On By Its Debt Load?
Apr 18Does Viridian Therapeutics (NASDAQ:VRDN) Have A Healthy Balance Sheet?
Jan 08Viridian: Excellent Early Data, Strong Cash, Great Strategy, Large Market
Sep 09Viridian Therapeutics board compensation committee approves inducement grants
Sep 02An Intrinsic Calculation For Viridian Therapeutics, Inc. (NASDAQ:VRDN) Suggests It's 49% Undervalued
Aug 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$257m |
| Jun 30 2024 | n/a | n/a | -US$228m |
| Mar 31 2024 | n/a | n/a | -US$218m |
| Dec 31 2023 | US$13m | US$113k | -US$238m |
Compensation vs Market: Steve's total compensation ($USD13.02M) is above average for companies of similar size in the US market ($USD5.43M).
Compensation vs Earnings: Insufficient data to compare Steve's compensation with company performance.
CEO
Steve Mahoney (53 yo)
1.1yrs
Tenure
US$13,022,654
Compensation
Mr. Stephen F. Mahoney, also known as Steve, J. D. serves as President, CEO & Director at Viridian Therapeutics, Inc. since October 30, 2023. He served as President, Chief Financial and Operating Officer a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.1yrs | US$13.02m | 0.027% $ 432.3k | |
| Senior VP of Finance and Accounting | 1.2yrs | US$6.67m | 0.0013% $ 20.2k | |
| Chief Operating Officer | 1.1yrs | US$5.17m | 0.0076% $ 121.1k | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
| Co-Founder & Scientific Advisor | no data | no data | no data | |
| Chief Legal Officer | less than a year | no data | no data | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Chief Human Resources Officer | less than a year | no data | no data | |
| Chief Commercial Officer | 1.6yrs | no data | no data | |
| Chief Medical Officer | 1.8yrs | no data | 0.00096% $ 15.4k |
1.1yrs
Average Tenure
53.5yo
Average Age
Experienced Management: VRDN's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.1yrs | US$13.02m | 0.027% $ 432.3k | |
| Co-Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Co-Founder & Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 6.8yrs | US$477.83k | 0% $ 0 | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Independent Chairperson of Board | 4.1yrs | US$503.83k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$467.83k | 0% $ 0 | |
| Independent Director | 4.1yrs | US$471.83k | 0% $ 0 |
4.1yrs
Average Tenure
53yo
Average Age
Experienced Board: VRDN's board of directors are considered experienced (4.1 years average tenure).